Preventing relapse of cancer in kids: iwilfin
Challenge: Make pediatric oncologists and caregivers aware of iwilfin, an oral tablet shown to reduce the risk of relapse of high-risk neuroblastoma.
Solution: For impact and memorability, we played off of the name of the drug, to express the determination of HCPs and caregivers to do all they can. Shown here are the conceptual adlobs that led to them to being used on the iwilfin website.
Solution: For impact and memorability, we played off of the name of the drug, to express the determination of HCPs and caregivers to do all they can. Shown here are the conceptual adlobs that led to them to being used on the iwilfin website.
Slowing the progress of Friedreich ataxia: Skyclarys
Challenge: Make HCPs aware of the first-ever treatment for Friedreich ataxia, a rare, progressive neuromuscular disorder.
Solution: Website highlighting key clinical results.
Solution: Website highlighting key clinical results.
Melanoma starts young. So don't be a dermass. Protect your skin.
Challenge: Make younger audiences aware that skin cancer can affect them, too.
Solution: "Don't be a dermass. Smart people wear sunscreen." Social campaign run by Boundless Life as part PSA / part creative showcase
Rx Club Award of Excellence, Nov 2024
Solution: "Don't be a dermass. Smart people wear sunscreen." Social campaign run by Boundless Life as part PSA / part creative showcase
Rx Club Award of Excellence, Nov 2024
A dosage for insomnia that could be ju-u-u-st right: Zolpidem 7.5 mg
Challenge: Make HCPs aware of a new 7.5 mg dosage of Zolpidem, to help them better target the needs of their patients with insomnia
Solution: Zolpidem website and profiles that HCPs could relate to—such as a patient new to Zolpidem, or someone who needed a slightly higher dose.
Solution: Zolpidem website and profiles that HCPs could relate to—such as a patient new to Zolpidem, or someone who needed a slightly higher dose.
How to sell a Covid vaccine when nobody wants one
|
|
Challenge: Remind people during Fall, that being indoors means greater exposure to Covid 19.
Solution: Rather than a scare tactic, we took a light-hearted approach: a social campaign "The Great Indoors," playing off the tone and look of classic advertising for exploring the Great Outdoors. Static posts and a music video with a nice, bouncy jingle.
GOLD AWARD WINNER! Titan Health Awards, Oct 2024
Solution: Rather than a scare tactic, we took a light-hearted approach: a social campaign "The Great Indoors," playing off the tone and look of classic advertising for exploring the Great Outdoors. Static posts and a music video with a nice, bouncy jingle.
GOLD AWARD WINNER! Titan Health Awards, Oct 2024
Mental health is health: Blue Cross and Blue Shield of NC
|
|
Challenge: Break the stigma against seeking help for mental health
Solution: Social campaign that flipped Blue Cross' historical "Live Fearless" theme to express a new meaning for fearless: asking for help. Appeared at holiday season, a stressful time of the year. Assets led to a webpage providing mental health resources.
And speaking of anxiety: LOREEV XR for simpler dosing and constant relief
Challenge: Inform HCPs and motivate them to consider switching patients from lorazepam TID to once-daily LOREEV XR.
Solution: Emails and banner ads led to this website for HCPs, which highlights the simplicity of once-daily dosing, potential for improved adherence, smooth PK profile, and LOREEV XR's unique metabolism, which helps reduce risk of drug-drug interactions.
Solution: Emails and banner ads led to this website for HCPs, which highlights the simplicity of once-daily dosing, potential for improved adherence, smooth PK profile, and LOREEV XR's unique metabolism, which helps reduce risk of drug-drug interactions.
